Pyrvinium

This classification denotes an antiparasitic agent with the molecular formula C26H28N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6B9991FLU3, chemically known as 6-(dimethylamino)-2-(2-(2,5-dimethyl-1-phenyl-1h-pyrrol-3-yl)ethenyl)-1-methylquinolinium but generally known as pyrvinium, which bears US NIH Compound Identifier 5281035. European Medicines Agency schedules Pyrvinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04153MIG. World Health Organization schedules pyrvinium in its Anatomical Therapeutic Chemical (ATC) Classification. PYRVINIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PYRVINIUM remains the US FDA Preferred Term for this commodity. Pyrvinium bears US NLM identifiers UMLS ID C0072804 and NCI Concept Code C77330. SMILES: N1(C(C(CC1C)/C=C/C1[N](C2C(CC(N(C)C)CC2)CC1)C)C)C1CCCCC1.